These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 8845268)

  • 1. Ultrasound and soft-tissue radiography to monitor local interferon-alpha 2B treatment in Peyronie's disease.
    Andresen R; Wegner HE; Banzer D; Miller K
    Acta Radiol; 1996 May; 37(3 Pt 1):352-6. PubMed ID: 8845268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local interferon-alpha 2b is not an effective treatment in early-stage Peyronie's disease.
    Wegner HE; Andresen R; Knispel HH; Miller K
    Eur Urol; 1997; 32(2):190-3. PubMed ID: 9286652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease.
    Kendirci M; Usta MF; Matern RV; Nowfar S; Sikka SC; Hellstrom WJ
    J Sex Med; 2005 Sep; 2(5):709-15. PubMed ID: 16422829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Peyronie's disease with local interferon-alpha 2b.
    Wegner HE; Andresen R; Knipsel HH; Miller K
    Eur Urol; 1995; 28(3):236-40. PubMed ID: 8536778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined intralesional interferon alpha 2B and oral vitamin E in the treatment of Peyronie's disease.
    Novak TE; Bryan W; Templeton L; Sikka S; Hellstrom WJ
    J La State Med Soc; 2001 Jul; 153(7):358-63. PubMed ID: 11519219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralesional Injection of Interferon-α2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location.
    Stewart CA; Yafi FA; Knoedler M; Mandava SH; McCaslin IR; Sangkum P; Sikka S; Trost L; Hellstrom WJ
    J Urol; 2015 Dec; 194(6):1704-7. PubMed ID: 26144333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study.
    Inal T; Tokatli Z; Akand M; Ozdiler E; Yaman O
    Urology; 2006 May; 67(5):1038-42. PubMed ID: 16581113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional interferon in the treatment of Peyronie's disease: a pilot study.
    Judge IS; Wisniewski ZS
    Br J Urol; 1997 Jan; 79(1):40-2. PubMed ID: 9043494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional interferon-alpha-2b for the treatment of Peyronie's disease.
    Lacy GL; Adams DM; Hellstrom WJ
    Int J Impot Res; 2002 Oct; 14(5):336-9. PubMed ID: 12454683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease.
    Ahuja S; Bivalacqua TJ; Case J; Vincent M; Sikka SC; Hellstrom WJ
    J Androl; 1999; 20(4):444-8. PubMed ID: 10452584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intralesional interferon-alpha-2B injections for the treatment of Peyronie's disease.
    Dang G; Matern R; Bivalacqua TJ; Sikka S; Hellstrom WJ
    South Med J; 2004 Jan; 97(1):42-6. PubMed ID: 14746421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease.
    Hellstrom WJ; Kendirci M; Matern R; Cockerham Y; Myers L; Sikka SC; Venable D; Honig S; McCullough A; Hakim LS; Nehra A; Templeton LE; Pryor JL
    J Urol; 2006 Jul; 176(1):394-8. PubMed ID: 16753449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peyronie's disease: intralesional treatment with interferon alpha-2A and evaluation of the results by magnetic resonance imaging.
    Polat O; Gül O; Ozbey I; Ozdikici M; Bayraktar Y
    Int Urol Nephrol; 1997; 29(4):465-71. PubMed ID: 9406006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imaging modalities in Peyronie's disease. An intrapersonal comparison of ultrasound sonography, X-ray in mammography technique, computerized tomography, and nuclear magnetic resonance in 20 patients.
    Andresen R; Wegner HE; Miller K; Banzer D
    Eur Urol; 1998 Aug; 34(2):128-34; discussion 135. PubMed ID: 9693248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intralesional recombinant interferon alpha-2b in Peyronie's disease.
    Astorga R; Cantero O; Contreras D; del Río-Martín A; Labarta-Beceiro V; Gutiérrez-Elvírez A; Lima-López MA; López-Saura P
    Arch Esp Urol; 2000 Sep; 53(7):665-71. PubMed ID: 11037665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Effect of Duration of Penile Traction Therapy in Patients Undergoing Intralesional Injection Therapy for Peyronie's Disease.
    Yafi FA; Pinsky MR; Stewart C; Sangkum P; Ates E; Trost LW; Sikka SC; Hellstrom WJ
    J Urol; 2015 Sep; 194(3):754-8. PubMed ID: 25804087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
    Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
    BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Peyronie's disease with local interferon-alpha 2b.
    Brake M; Loertzer H; Horsch R; Keller H
    BJU Int; 2001 May; 87(7):654-7. PubMed ID: 11350406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ultrasound-guided ESWT in Peyronie's disease plaques].
    Mirone V; Palmieri A; Granata AM; Piscopo A; Verze P; Ranavolo R
    Arch Ital Urol Androl; 2000 Dec; 72(4):384-7. PubMed ID: 11221076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical management of Peyronie's disease.
    Hellstrom WJ
    J Androl; 2009; 30(4):397-405. PubMed ID: 18974422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.